---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291579484.md"
description: "Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72."
datetime: "2026-07-02T18:33:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291579484.md)
  - [en](https://longbridge.com/en/news/291579484.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291579484.md)
---

# 

Burning Rock Biotech shares are trading higher after the company announced its founder, chairman and CEO, Yusheng Han, has purchased 73,141 ADSs for $618,217.72.

### Related Stocks

- [BNR.US](https://longbridge.com/en/quote/BNR.US.md)

## Related News & Research

- [Major Insider Move Signals Growing Confidence in Burning Rock Biotech](https://longbridge.com/en/news/291621339.md)
- [A $3.8 Billion Reason Why Procter & Gamble Stock Is in Focus Today](https://longbridge.com/en/news/294987679.md)
- [Azenta Q3 adjusted EPS beats estimates, revenue rises 12%](https://longbridge.com/en/news/294869775.md)
- [IDEAYA Q2 2026 earnings: Darovasertib NDA advances with $1.24 billion in cash](https://longbridge.com/en/news/294919298.md)
- [ARDT: Revenue and EBITDA declined, but cash flow and admissions improved; guidance reaffirmed](https://longbridge.com/en/news/294867943.md)